The plight of older Australians grappling with motor neurone disease (MND) has thrust the debate on euthanasia into the spotlight, as the high costs of managing this debilitating condition push patients towards premature death. Glenn Rowan, a 78-year-old MND sufferer, faces a stark choice: either deplete his savings to fund 24/7 care or opt for early euthanasia. This dilemma is not unique to Rowan; it reflects a systemic issue within the aged care system, which fails to adequately support those with severe disabilities like MND.
What makes this particularly fascinating is the stark contrast between the funding available through the National Disability Insurance Scheme (NDIS) and the aged care system. While individuals diagnosed with MND before turning 65 are eligible for the NDIS, offering up to $300,000 in funding, those diagnosed after 65, like Rowan, are relegated to the aged care system, which provides a fraction of that amount. This disparity highlights the need for a more comprehensive and equitable support system for older Australians with MND.
In my opinion, the recent fast-tracked aged care funding for people over 65 diagnosed with MND is a step in the right direction. However, it falls short of addressing the fundamental issue of inadequate funding. The government's automated assessment tool, designed to determine funding levels, often fails to categorize individuals with MND at the highest funding level, resulting in insufficient support. This raises a deeper question: how can we ensure that the aged care system is equipped to handle the unique needs of those with severe physical disabilities like MND?
One thing that immediately stands out is the lack of price caps regulating the increased cost of at-home care services for individuals with MND. This means that the funding support they receive buys them less, exacerbating the financial burden on families. The situation is further complicated by the rapid physical deterioration associated with MND, which sets it apart from other neurological diseases typically associated with ageing. The aged care residential sector, designed for Alzheimer's disease, is ill-equipped to handle the severe physical disability of MND patients.
From my perspective, the case of Glenn Rowan and others like him highlights the urgent need for a more holistic and compassionate approach to aged care. The government must take proactive steps to ensure that individuals with MND receive the necessary support, including adequate funding and access to voluntary assisted dying. By doing so, we can provide some dignity and comfort to those in the last part of their lives, while also alleviating the financial burden on their families. This is not just a matter of compassion; it is a matter of ensuring that our aged care system is fit for purpose and equipped to handle the diverse needs of our aging population.
